Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus

C G Bremner1, R M Bremner

  • 1Department of Surgery, University of Southern California, Los Angeles, USA.

The Surgical Clinics of North America
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Gastroesophageal reflux can cause columnar replacement of the esophagus, leading to Barrett's esophagus and increasing adenocarcinoma risk. Early diagnosis and treatment, including surgery, improve outcomes for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Squamous Cell Carcinoma After Pulmonary Aspergillosis in the Native Lung of a Lung Transplant Recipient: A Case Report.

Transplantation proceedings·2018
Same author

Thoracoabdominal pressure gradient and gastroesophageal reflux: insights from lung transplant candidates.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same author

Swallow-induced esophageal shortening in patients without hiatal hernia is associated with gastroesophageal reflux.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same author

Proceedings from an international conference on ablation therapy for Barrett's mucosa: Brittany, France, 31 August - 2 September 1997.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Bravo capsule induction of esophageal hypercontractility and chest pain.

Surgical endoscopy·2006
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Oncology
  • Esophageal Diseases

Background:

  • Gastroesophageal reflux disease (GERD) is a primary cause of esophageal columnar metaplasia, known as Barrett's esophagus.
  • Barrett's esophagus is a premalignant condition associated with an increased risk of esophageal adenocarcinoma.
  • The role of duodenal contents in the pathogenesis of Barrett's esophagus and its complications is increasingly recognized.

Purpose of the Study:

  • To review the pathophysiology, complications, and management of Barrett's esophagus.
  • To highlight the rising incidence of esophageal adenocarcinoma in the Western world.
  • To discuss current and emerging treatment strategies for GERD and Barrett's esophagus.

Main Methods:

  • Review of existing literature on gastroesophageal reflux, Barrett's esophagus, and esophageal adenocarcinoma.

Related Experiment Videos

  • Analysis of epidemiological trends and risk factors.
  • Evaluation of the efficacy of medical and surgical treatments, including surveillance, antireflux therapies, and mucosal ablation.

    • Main Results:

    • Columnar metaplasia (Barrett's esophagus) develops secondary to chronic gastroesophageal reflux.
    • Barrett's esophagus is a significant risk factor for esophageal adenocarcinoma, with increasing incidence.
    • Surgical antireflux treatment, particularly minimally invasive approaches, shows better overall results than proton pump inhibition for symptom relief and potentially disease progression.

    Conclusions:

    • Barrett's esophagus represents a serious complication of GERD with a rising cancer risk.
    • Surveillance programs aid in early diagnosis and improve survival rates after resection.
    • While medical and surgical antireflux treatments manage symptoms, novel therapies like mucosal ablation are under investigation.